PATENT CLAIM ANALYSIS

Application Number: 15935707
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "484000"]

Abstract:
Described is a formulation and method for reducing and treating bacterial infections in humans and animals with digested or non-digested extracellular matrix materials derived from non-epithelial and epithelial tissues.

Claim (Index 18):
A method for protecting a mammal from a bacterial-induced infection, comprising:\n providing a reconstituted material comprising a micronized powder in a buffer solution obtained from a devitalized extracellular matrix material of an epithelial tissue, said reconstituted material comprising one or more native components of the extracellular matrix; and administering said material in a therapeutically effective dose by a route selected from the group consisting of intra-tracheal instillation, intra-nasal instillation-inhalation, spray, topical application, and combinations thereof.

Metadata:
- Claim Count in Document: 95.0
- Percentile: 90.0
- Lexical Diversity: 1.11111
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13566816', '15380648', '15335156', '14382837', '13909618']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6898443935397799
- 35 USC 102 Novelty (BERT): 0.5176987072556591
- Combined Prediction Score: 0.6726298249113678
- Mean Citation Score: 266.357744
- Max Citation Score: 283.3307200000001
- Similarity Product: 194.80334648588183

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test